Objective: First cases of osteonecrosis of the jaw in patient exposed to bisphosphonates were presented in 2003. Bisphosphonates related osteonecrosis of the jaw (BRONJ) was further extended to medication-related osteonecrosis of the jaw (MRONJ) to include antiresorptive and anti-angiogenic drugs. Some directives were described for the treatment of this disease in function of its gravity. Treatments of high stage of MRONJ are subject to discussion because of their morbidity. Complete healing is difficult to reach and often needs combination of invasive and non-invasive treatment. Case report: We report and illustrate a clinical case of new bone formation after MRONJ on pamidronate and zoledronate treatment for multiple myeloma. The treatmen...
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is mainly reported in patients with bone m...
Bisphosphonates are the most widely prescribed drugs for the treatment of osteoporosis, and are also...
Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but serious adverse effect of certain...
Purpose: To review the main clinical-radiographic, therapeutic, and preventive aspects of osteonecro...
Aim: To report a series of thirty cases of bisphosphonate-related osteonecrosis of the jaw (BRONJ). ...
The clinical management of medication-related osteonecrosis of the jaw (MRONJ) in patients treated w...
Background: Bisphosphonates (BPs) and other antiresorptive agents such as denosumab are widely presc...
Introduction and Objective: Medication-related osteonecrosis of the jaw (MRONJ) is a recently descri...
Osteonecrosis of the jaw (ONJ) has been reported as uncommon but well recognised complication assoc...
The antiresorptive drugs bisphosphonates and denosumab arewidely used to preserve bone strength by i...
The use of bisphosphonates (BPs) has proven effective in the treatment of bone-related diseases, des...
Introduction: Bisphosphonates are efficiently used to treat osteoporosis, bone metastases of maligna...
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) occurs by the use of a drug that h...
Bisphosphonates (BPs) are used intravenously to treat cancer-related conditions for the prevention o...
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is a severely debilitating conditi...
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is mainly reported in patients with bone m...
Bisphosphonates are the most widely prescribed drugs for the treatment of osteoporosis, and are also...
Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but serious adverse effect of certain...
Purpose: To review the main clinical-radiographic, therapeutic, and preventive aspects of osteonecro...
Aim: To report a series of thirty cases of bisphosphonate-related osteonecrosis of the jaw (BRONJ). ...
The clinical management of medication-related osteonecrosis of the jaw (MRONJ) in patients treated w...
Background: Bisphosphonates (BPs) and other antiresorptive agents such as denosumab are widely presc...
Introduction and Objective: Medication-related osteonecrosis of the jaw (MRONJ) is a recently descri...
Osteonecrosis of the jaw (ONJ) has been reported as uncommon but well recognised complication assoc...
The antiresorptive drugs bisphosphonates and denosumab arewidely used to preserve bone strength by i...
The use of bisphosphonates (BPs) has proven effective in the treatment of bone-related diseases, des...
Introduction: Bisphosphonates are efficiently used to treat osteoporosis, bone metastases of maligna...
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) occurs by the use of a drug that h...
Bisphosphonates (BPs) are used intravenously to treat cancer-related conditions for the prevention o...
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is a severely debilitating conditi...
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is mainly reported in patients with bone m...
Bisphosphonates are the most widely prescribed drugs for the treatment of osteoporosis, and are also...
Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but serious adverse effect of certain...